Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00247-006-0279-y | DOI Listing |
Skeletal Radiol
November 2024
Department of Radiology at UTHealth McGovern School of Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Osteoarthritis can be treated with hyaluronic acid derivatives, such as Durolane manufactured by Bioventus (Hill, 2017), particularly when conventional treatments prove ineffective. In osteoarthritic joints, the synovial fluid has a lower concentration of hyaluronic acid compared to healthy joints. Intra-articular therapy with exogenous hyaluronic acid can improve viscoelastic properties, enhance chondrocyte synthesis, reduce cartilage degradation, and alleviate pain associated with osteoarthritis (Migliore and Procopio in Clin Cases Miner Bone Metab.
View Article and Find Full Text PDFFront Bioeng Biotechnol
July 2024
Department of Orthopedic Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States.
J Ultrasound
December 2024
Regenerative Medicine Laboratory, Petrópolis Medical School/UNIFASE, Av. Barão do Rio Branco, 1003-Centro, Petrópolis, RJ, 25680-120, Brazil.
Skeletal Radiol
January 2025
Radiology Department, La Paz University Hospital, Madrid, Spain.
Acta Ortop Mex
March 2024
Departamento de Ortopedia, Centro Médico Imbanaco. Cali, Colombia.
Introduction: knee osteoarthritis (KOA) is known as the most common form of osteoarthrosis with a 6% prevalence in people over 30 years old, and more than 40% in the population over 70 years old. The use of PRP led to diverse results and this disparity can be attributed to the dissimilar methods of PRP preparation. This study aims to assess the functional effects of intraosseous (IO) and intraarticular (IA) injections of platelet rich plasma (PRP) followed by IA injections of hyaluronic acid (HA).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!